Clinical Trials · NCT01264497
Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Theratechnologies
- Enrollment
- 55
- Start date
- Feb 2002
- Locations
- See registry
- Primary endpoint
- Change from baseline in relative insulin response